TARRYTOWN, N.Y., Oct. 21, 2016 /PRNewswire/ -- Regeneron
Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast its presentation
at the 25th Annual Credit Suisse Healthcare Conference
at 10:00 a.m. ET on Tuesday, November 8, 2016.
The session may be accessed through the Company's web site,
www.regeneron.com, on the 'Events and Presentations' page.
Archived versions of the presentations will be available for 30
days.
About Regeneron Pharmaceuticals, Inc.
Regeneron (NASDAQ: REGN) is a leading science-based
biopharmaceutical company based in Tarrytown, New York that discovers, invents,
develops, manufactures, and commercializes medicines for the
treatment of serious medical conditions. Regeneron commercializes
medicines for eye diseases, high LDL cholesterol and a rare
inflammatory condition, and has product candidates in development
in other areas of high unmet medical need, including rheumatoid
arthritis, asthma, atopic dermatitis, pain, oncology, and
infectious diseases. For additional information about the company,
please visit www.regeneron.com or follow @Regeneron on Twitter.
|
Contact
Information:
|
|
|
|
|
Investor
Relations
|
Corporate
Communications
|
|
Manisha Narasimhan,
Ph.D.
|
Hala Mirza
|
|
914.847.5126
|
914.847.3422
|
|
manisha.narasimhan@regeneron.com
|
hala.mirza@regeneron.com
|
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/regeneron-announces-presentation-at-the-25th-annual-credit-suisse-healthcare-conference-300348597.html
SOURCE Regeneron Pharmaceuticals, Inc.